RecruitingNot applicableNCT04362592
In-Utero Endoscopic Correction of Spina Bifida
Studying Neural tube defect
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Southern California
- Principal Investigator
- Ruben Quintero, MD, M.DUS Fetus
- Intervention
- In Utero Endoscopic Correction of Myelomeningocele IDE - Percutaneous Technique(device)
- Enrollment
- 110 enrolled
- Eligibility
- 18-52 years · FEMALE
- Timeline
- 2018 – 2031
Study locations (2)
- Hollywood Presbyterian Medical Center, Los Angeles, California, United States
- Wellington Regional Medical Center, Wellington, Florida, United States
Collaborators
USFetus
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04362592 on ClinicalTrials.govOther trials for Neural tube defect
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06946563Fetoscopic Neural Tube Defect RepairOregon Health and Science University
- RECRUITINGNANCT05672849Safety and Efficacy of Devices Used in Fetoscopic Neural Tube Defect Repair CasesMichael A Belfort
- ACTIVE NOT RECRUITINGPHASE1NCT03794011Patch vs. No Patch Fetoscopic Meningomyelocele Repair StudyBaylor College of Medicine
- RECRUITINGNANCT03856034Laparotomy Versus Percutaneous Endoscopic Correction of MyelomeningoceleUSFetus
- ACTIVE NOT RECRUITINGNANCT03090633Fetoscopic Repair of Isolated Fetal Spina BifidaJohns Hopkins University